Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Kenvue (NYSE:KVUE) through any online brokerage.
Other companies in Kenvue’s space includes: Unilever PLC (NYSE:UL), The Estee Lauder Companies Inc (NYSE:EL), e.l.f. Beauty Inc (NYSE:ELF), Interparfums Inc (NASDAQ:IPAR) and Coty Inc (NYSE:COTY).
Kenvue has a consensus price target of $20.59.
The stock price for Kenvue (NYSE: KVUE) is $19.86 last updated October 22, 2026 at 7:58 PM EDT.
There are no upcoming dividends for Kenvue.
Kenvue does not have any upcoming earnings scheduled.
There is no upcoming split for Kenvue.
Kenvue is in the Consumer Staples sector and Personal Products industry. They are listed on the NYSE.